Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
CDAD is the major known cause of antibiotic-induced diarrhea and colitis, and the disease is thought to result from persistent disruption of commensal gut microbiota.Bacteriotherapy by way of fecal transplantation can be used to treat recurrent CDAD and is thought to re-establish the normal colonic microflora.However, limitations of conventional microbiologic techniques have until recently precluded testing of this idea.In this study we used T-RFLP and 16S rRNA gene sequencing approaches to characterize the bacterial composition of the colonic microflora in a patient suffering from recurrent CDAD, before and after treatment by fecal transplantation from a healthy donor.While the patient's residual colonic microbiota, prior to therapy, was deficient in members of the bacterial divisions-Firmicutes and Bacteriodetes, transplantation had a dramatic impact on the composition of the patient's gut microbiota.By 14 days post transplantation, the fecal bacterial composition of the recipient was highly similar to the donor and was dominated by Bacteroides spp.strains and an uncharacterized butyrate producing bacterium.The change in bacterial composition was accompanied by resolution of the patient's symptoms.The striking similarity of the recipient's and donor's intestinal microbiota following bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches, resulting in restoration of both the structure and function of the microbial communities present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies have demonstrated remarkable effectiveness of FMT in cases of recurrent and refractory CDI, which may be attributed to sustained restoration of the normal microbiota after FMT.22,23”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“Moreover, the restoration of more typical microbial communities, which come to resemble those of the donor post-transplant, persists in a durable fashion after FMT.6, 7”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“FMT appears to result in durable engraftment of new species from donor as well as augmentation of species present at only very low levels prior to FMT6.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Many Firmicutes produce butyrate and are postulated to be involved in obesity in humans and murine models.(32,33) Short chain length fatty acids (SCFAs), especially butyrate, have also been shown to play a critical role in maintaining integrity of the colonic epithelium and regulation of the mucosal immune responses.”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“These bacteria are well-known dominant members of human fecal microbiota,(16) and these phyla are thought to play major ecologic roles in establishment and maintenance of gut homeostasis.(30) A lack of Bacteroides sp.”
BackgroundDevelopment of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Edwards, U., Rogall, T., Blöcker, H., Emde, M., & Böttger, E. C. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.19.7843 · Cited by 2,724 · cited 1×
“primers Bact-8F (5’-AGAGTTTGATCCTGGCTCAG-3’) [25] 5′ end-labeled with 6-”
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313 · cited 4×
“Unfortunately, the same problem is encountered by others treating this disease.(1) In the studies reported here, we used a molecular approach to gain a better understanding of the bacterial composition of the GI tract in a CDAD patient.”
BackgroundInfluentialDecreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010 · cited 2×
“However, the composition and species richness of intestinal tract microbiota in individuals with CDAD and recurrent CDAD were found to be markedly different from controls.(14) The reestablishment of the normal composition of the intestinal flora has long been hypothesized to be a curative approach for the recurrent CD…”
Background
Cited by
Items 201–300 of 645
Clostridium Difficile Infection
Luciano, J. A., & Zuckerbraun, B. S. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.08.006 · Cited by 80
Dang, X., Xu, M., Liu, D., Zhou, D., & Yang, W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228846 · Cited by 87
“Microbiological analysis has been performed in many studies, indicating that the diversity of the gut microbiota in the recipient increases after FMT, and the composition of the gut microbiota changes to be similar to the donor [61].”
BackgroundReverse Ecology: From Systems to Environments and Back
Levy, R., & Borenstein, E. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3567-9_15 · Cited by 85
“Ultimately, predictive modeling of community metabolism and rational design of artificial microbiomes may provide an exciting framework for guiding clinical interventions in the human microbiome and the design of transplantable microbiomes with desired metabolic activities [52].”
BackgroundBella, S. D., Gouliouris, T., & Petrosillo, N. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.01.011 · Cited by 77
Damman, C. J., Brittnacher, M. J., Westerhoff, M., Hayden, H. S., Radey, M., Hager, K. R., Marquis, S. R., Miller, S. I., & Zisman, T. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133925 · Cited by 74
“[10] They are also contrary to engraftment studies in CDI and animal models showing that transplanted microbiota are stable for up to a year.[32,33] The lack of sustained Table 3.”
ResultParker, W., & Ollerton, J. (2013) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eot008 · Cited by 73
Vujkovic-Cvijin, I., Rutishauser, R. L., Pao, M., Hunt, P. W., Lynch, S. V., McCune, J. M., & Somsouk, M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1334034 · Cited by 80
“[22, 82 23] Given that FMT can restructure the composition of the gut microbiome to resemble that of the healthy donor in 83 CDI subjects,[24] we hypothesized that this intervention might reverse gut microbial dysbiosis and reduce markers of 84 immune activation and inflammation in ART-treated HIV-infected individuals.”
BackgroundTang, G., Yin, W., & Liu, W. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.05.007 · Cited by 72
Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infections
Austin, M., Mellow, M., & Tierney, W. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.02.017 · Cited by 78
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
Matijašić, M., Meštrović, T., Perić, M., Paljetak, H. Č., Panek, M., Bender, D. V., Kelečić, D. L., Krznarić, Ž., & Verbanac, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040578 · Cited by 76
“FMT was first proposed as a CDI therapy in 1983 [139] and was soon found to be an ideal treatment for the disease, restoring the balance of intestinal microbiota in stable and durable manner [140].”
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease
Vaughn, B. P., Rank, K. M., & Khoruts, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.026 · Cited by 70
“The term FMT supplanted earlier names such as bacteriotherapy or human probiotic infusion after documentation that infusion of donor fecal material results in prompt and sustained engraftment of donor bacteria.(3,4) The word microbiota refers to live microbial communities, and in addition to bacteria, feces also conta…”
BackgroundSelf-citationWhat are the effects of proton pump inhibitors on the small intestine?
Fujimori, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i22.6817 · Cited by 70
Fecal Transplantation for Recurrent C lostridium difficile Infection in Older Adults: A Review
Burke, K. E., & LaMont, J. T. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12378 · Cited by 77
“5 3 Khoruts et al.(21) 1 61 0/1 N/A >9 6 Rohlke et al.”
BackgroundMethodAhmed, E., & Hens, K. (2021) · AJOB Neuroscience · doi:10.1080/21507740.2021.1958096 · Cited by 73
“Moreover, the dynamic nature of the human microbiome signifies the promises of its therapeutic interventions and controlled manipulations to restore mental health (Khoruts et al. 2010).”
BackgroundAntimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
Vincent, C., & Manges, A. R. (2015) · Antibiotics · doi:10.3390/antibiotics4030230 · Cited by 82
“Khoruts and colleagues assessed the composition of the fecal microbiota in a single patient with relapsing CDI who underwent FMT via colonoscopy [81].”
BackgroundHuman Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 77
Clostridium difficile Infection and Fecal Microbiota Transplant
Liubakka, A., & Vaughn, B. P. (2016) · AACN Advanced Critical Care · doi:10.4037/aacnacc2016703 · Cited by 71
“Patients with recurrent CDI are deficient in the bacterial phyla that normally dominate the colon, which may predispose them to multiple recurrences.(30) Risk Factors for C difficile”
BackgroundGenomics and transcriptomics in drug discovery
Dopazo, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.003 · Cited by 74
Doré, J., Simrén, M., Buttle, L., & Guarner, F. (2013) · United European Gastroenterology Journal · doi:10.1177/2050640613502477 · Cited by 65
“Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.(46) J Clin”
BackgroundGhimire, S., Roy, C., Wongkuna, S., Antony, L., Fenske, G. J., Maji, A., Keena, M. C., Foley, A., & Scaria, J. (2020) · mSystems · doi:10.1128/msystems.00620-19 · Cited by 79
“Infusion of the fecal microbiome from a healthy person into the gut of a patient with CDI can resolve CDI and prevent recurrence (6, 7).”
BackgroundA. Frese, S., W. Hutkins, R., & Walter, J. (2012) · Advances in Microbiology · doi:10.4236/aim.2012.23051 · Cited by 66
“If community structure becomes disrupted, for example through a high dose of antibiotics, microbes from another individual can be successfully and more permanently established [40].”
BackgroundEmanuelsson, F., Claesson, B. E. B., Ljungström, L., Tvede, M., & Ung, K.-A. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.858181 · Cited by 68
The host immune response to Clostridium difficile infection
Solomon, K. (2013) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936112472173 · Cited by 109
“2011; Postigo and Kim, 2012] and the microbiota has been shown to resemble that of the donor after infusion [Khoruts et al. 2010].”
BackgroundVemuri, R. C., Gundamaraju, R., Shinde, T., & Eri, R. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0115 · Cited by 66
Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
Yoon, S. S., & Sun, J. (2011) · Gastroenterology Research and Practice · doi:10.1155/2011/971938 · Cited by 66
“A recent study showed that fecal bacteriotherapy was effective in relief of clinical symptoms in a patient with recurrent CDAD and that this was accompanied by the repopulation of the diseased intestinal microbiota with beneficial species that were diminished pretreatment [75].”
BackgroundSensitivity to oxazolone induced dermatitis is transferable with gut microbiota in mice
Zachariassen, L. F., Krych, L., Engkilde, K., Nielsen, D. S., Kot, W., Hansen, C. H. F., & Hansen, A. K. (2017) · Scientific Reports · doi:10.1038/srep44385 · Cited by 66
Madoff, S. E., Urquiaga, M., Alonso, C. D., & Kelly, C. P. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.102098 · Cited by 68
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Cohen, N. A., & Maharshak, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4535-9 · Cited by 71
“Performing FMT in these patients demonstrated that microbial alterations of postFMT are durable, mostly safe and carry relatively few side effects [12, 13].”
Clostridioides difficile LuxS mediates inter-bacterial interactions within biofilms
Slater, R. T., Frost, L. R., Jossi, S. E., Millard, A. D., & Unnikrishnan, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46143-6 · Cited by 74
“difficile colonisation and disease [8, 10-13].”
Greenblum, S., Chiu, H.-C., Levy, R., Carr, R., & Borenstein, E. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.04.001 · Cited by 65
Trubiano, J. A., Gardiner, B., Kwong, J. C., Ward, P., Testro, A. G., & Charles, P. G. P. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835b2da9 · Cited by 64
Effects of Pasture Grass, Silage, and Hay Diet on Equine Fecal Microbiota
Zhu, Y., Wang, X., Deng, L., Chen, S., Zhu, C., & Li, J. (2021) · Animals · doi:10.3390/ani11051330 · Cited by 71
“In humans, decreases in microbial diversity and richness have been associated with some GIT disorders such as chronic diarrhea [51].”
BackgroundTavoukjian, V. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.03.010 · Cited by 69
Sanders, N. L., Bollinger, R. R., Lee, R., Thomas, S., & Parker, W. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i34.5607 · Cited by 68
Fecal microbiota transplantation: current status and future directions
Borody, T. J., & Campbell, J. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.71 · Cited by 68
Intricacies of assessing the human microbiome in epidemiologic studies
Robinson, C. K., Brotman, R. M., & Ravel, J. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.04.005 · Cited by 83
“, healthy microbiota) to treat patients with recurrent Clostridium difficile infection [99, 100].”
BackgroundMcKinney, C. A., Oliveira, B. C. M., Bedenice, D., Paradis, M. R., Mazan, M. R., Sage, S. E., Sanchez, A., & Widmer, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230148 · Cited by 67
“difficile infection (CDI) in humans.[32, 33] Fig 4.”
Microbial Community Transplant Results in Increased and Long-Term Oxalate Degradation
Miller, A. W., Oakeson, K. F., Dale, C., & Dearing, M. D. (2016) · Microbial Ecology · doi:10.1007/s00248-016-0800-2 · Cited by 63
“The use of fecal microbial transplants often results in a more persistent shift of the recipient’s microbiota for several months to up to a year or more after the initial transplant [50–53].”
BackgroundGut microbiota and hematopoietic stem cell transplantation: where do we stand?
Zama, D., Biagi, E., Masetti, R., Gasperini, P., Prete, A., Candela, M., Brigidi, P., & Pession, A. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.173 · Cited by 63
Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions
Mullen, K. R., Yasuda, K., Divers, T. J., & Weese, J. S. (2016) · Equine Veterinary Education · doi:10.1111/eve.12559 · Cited by 72
“Some studies indicate that human patients receiving FMT for treatment of recurrent CDI commonly have clinical resolution of diarrhoea before they have evidence of faecal microbiota recovery (Khoruts et al. 2010; van Nood et al. 2013; Song et al. 2013) suggesting that the resolution of diarrhoea is related to factors o…”
BackgroundA review of the abundance, behaviour and detection of clostridial pathogens in agricultural soils
Palmer, J. S., Hough, R. L., West, H., & Avery, L. M. (2019) · European Journal of Soil Science · doi:10.1111/ejss.12847 · Cited by 63
Patel, N. C., Griesbach, C. L., DiBaise, J. K., & Orenstein, R. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.04.022 · Cited by 68
“This patient had previously undergone a subtotal colectomy for chronic colonic megacolon and had recurrent anastomotic obstruction and a chronically dilated small bowel in addition to the recurrent CDI.”
BackgroundInfluentialDing, S., Ma, Y., Liu, G., Yan, W., Jiang, H., & Fang, J. Q. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01152 · Cited by 67
Molecular Characterization of Fecal Microbiota in Patients with Viral Diarrhea
Ma, C., Wu, X., Nawaz, M., Li, J., Yu, P., Moore, J. E., & Xu, J. (2011) · Current Microbiology · doi:10.1007/s00284-011-9972-7 · Cited by 60
“Microbial diversity is essential for the proper role of this so-called microbial organ [10, 35] and changes in its composition have been linked with different metabolic disorders [1, 30] and infections [12].”
BackgroundFaa, G., Gerosa, C., Fanni, D., Nemolato, S., van Eyken, P., & Fanos, V. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.829700 · Cited by 58
“, is delayed in pretern infants, whereas the number of potentially pathogenic bacteria is high in preterms [42].”
BackgroundDurrer, A., Gumiere, T., Taketani, R. G., da Costa, D. P., Silva, M. D. C. P. E., & Andreote, F. D. (2016) · Applied Soil Ecology · doi:10.1016/j.apsoil.2016.11.005 · Cited by 60
Perler, B. K., Chen, B., Phelps, E. L., Allegretti, J. R., Fischer, M., Ganapini, V., Krajicek, E. J., Kumar, V., Marcus, J., Nativ, L., et al. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001281 · Cited by 60
Mamo, Y., Woodworth, M. H., Wang, T. L., Dhere, T., & Kraft, C. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1097 · Cited by 66
“FMT involves transfer of a healthy donor’s stool to a patient’s gastrointestinal tract in an attempt to restore a healthy microbiota [7].”
Background[Progress in the knowledge of the intestinal human microbiota].
Robles, V., & Guarner, F. (2013) · PubMed · doi:10.3305/nh.2013.28.3.6601 · Cited by 88
A unified conceptual framework for prediction and control of microbiomes
Stegen, J., Bottos, E. M., & Jansson, J. K. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.06.002 · Cited by 64
Self-citationTreatment of recurrent Clostridium difficile colitis: a narrative review
Hopkins, R. J., & Wilson, R. B. (2017) · Gastroenterology report · doi:10.1093/gastro/gox041 · Cited by 63
Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
Segni, A. D., Braun, T., BenShoshan, M., Barhom, S. F., Saar, E. G., Cesarkas, K., Squires, J. E., Keller, N., & Haberman, Y. (2018) · Journal of Visualized Experiments · doi:10.3791/56845 · Cited by 60
Świątczak, B., & Rescigno, M. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.004 · Cited by 57
Fecal microbiota transplantation and donor standardization
Owens, C., Broussard, E. K., & Surawicz, C. M. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.07.003 · Cited by 56
Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
Vasilescu, I.-M., Chifiriuc, M. C., Pîrcălăbioru, G. G., Filip, R., Bolocan, A., Lazăr, V., Diţu, L.-M., & Bleoţu, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651081 · Cited by 61
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Rosean, C. B., Feng, T.-Y., Azar, F. N., & Rutkowski, M. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.005 · Cited by 55
“Transplanting fecal microbiota from a healthy subject into a diseased subject can alter the composition of commensal microbes in the transplant recipient (Khoruts et al., 2010).”
BackgroundMusgrave, C. R., Bookstaver, P. B., Sutton, S. S., & Miller, A. D. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.03.017 · Cited by 50
A wise consistency: engineering biology for conformity, reliability, predictability
Arkin, A. P. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.09.012 · Cited by 61
Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future
Panchal, P., Budree, S., Scheeler, A., Medina, G., Seng, M., Wong, W. F., Eliott, R., Mitchell, T., Kassam, Z., Allegretti, J. R., et al. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0619-8 · Cited by 57
Liang, W., Zhao, L., Zhang, J., Fang, X., Zhong, Q., Liao, Z., Wang, J., Guo, Y., Liang, H., & Wang, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01221 · Cited by 55
Liu, T., Yang, Z., Zhang, X., Han, N., Yuan, J., & Cheng, Y. S. (2017) · 3 Biotech · doi:10.1007/s13205-017-0997-x · Cited by 53
Park, H., Laffin, M. R., Jovel, J., Millan, B., Hyun, J. E., Hotte, N., Kao, D., & Madsen, K. L. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1586037 · Cited by 49
den Abbeele, P. V., Verstraete, W., Aidy, S. E., Geirnaert, A., & de Wiele, T. V. (2013) · Microbial Biotechnology · doi:10.1111/1751-7915.12049 · Cited by 58
“difficile-associated disease (Khoruts et al., 2010; Guo et al., 2012), which is thought to result from persistent disruption of the Non-meandering gut microbiome Limited microbial cross-feeding = Reduced biodiversity Western society practices (caesarian sections, formula milk, antibiotics, western diet .”
BackgroundMethodSchoster, A., Guardabassi, L., Staempfli, H. R., Abrahams, M., Jalali, M., & Weese, J. S. (2015) · Equine Veterinary Journal · doi:10.1111/evj.12524 · Cited by 57
Aw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 57
Therapeutic manipulation of the microbiota: past, present, and considerations for the future
Young, V. B. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.001 · Cited by 54
“difficile infection is also associated with reduced microbiota diversity [18] and several investigators have noted that successful fecal transplantation is associated with a corresponding increase in intestinal microbiome diversity [20, 21].”
BackgroundSugita, K., Yanuma, N., Ohno, H., Takahashi, K., Kawano, K., Morita, H., & Ohmori, K. (2019) · BMC Veterinary Research · doi:10.1186/s12917-018-1754-z · Cited by 53
Fecal microbiota transplantation: current clinical efficacy and future prospects
Surawicz, C. M., Bowman, K. A., & Broussard, E. K. (2015) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s61305 · Cited by 53
“Recipient microbiota was similar to donor stool at 2 weeks and 33 days posttransplant, with dominance of Bacteroides species.(2) Rates of CDI were low and stable for decades until the year 2000, when more virulent strains of C.”
InfluentialKhoruts, A., & Weingarden, A. R. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.016 · Cited by 47
Self-citationContemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans
Staley, C. M., Khoruts, A., & Sadowsky, M. J. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.006 · Cited by 50
Self-citationMassive metagenomic data analysis using abundance-based machine learning
Harris, Z. N., Dhungel, E., Mosior, M., & Ahn, T.-H. (2019) · Biology Direct · doi:10.1186/s13062-019-0242-0 · Cited by 50
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection
Solbach, P., Chhatwal, P., Woltemate, S., Tacconelli, E., Buhl, M., Gerhard, M., Thoeringer, C. K., Vehreschild, M. J. G. T., Jazmati, N., Rupp, J., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196977 · Cited by 46
Gilis, E., Mortier, C., Venken, K., Debusschere, K., Vereecke, L., & Elewaut, D. S. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.180135 · Cited by 49
Clostridium difficile Infection
Gerding, D. N., & Young, V. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00245-9 · Cited by 44
Interaction of Gut Microbiota with Endocrine Homeostasis and Thyroid Cancer
Liu, Q., Sun, W., & Zhang, H. (2022) · Cancers · doi:10.3390/cancers14112656 · Cited by 48
“However, abnormalities in the composition of the intestinal flora are associated with many diseases, including metabolic and endocrine disorders [9,10].”
BackgroundAt least it won’t hurt: the personal risks of antibiotic exposure
Stewardson, A. J., Huttner, B. D., & Harbarth, S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.06.011 · Cited by 45
“Resolution of symptoms occurred in conjunction with a change in her intestinal commensal flora to closely resemble the donor’s [18].”
BackgroundMicrobiota transplant therapy and autism: lessons for the clinic
Adams, J. B., Borody, T. J., Kang, D., Khoruts, A., Krajmalnik‐Brown, R., & Sadowsky, M. J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1687293 · Cited by 49
Self-citationFerreyra, J. A., Ng, K. M., & Sonnenburg, J. L. (2014) · Cellular Microbiology · doi:10.1111/cmi.12300 · Cited by 45
“Studies on FMT in humans and mice demonstrate that pathogen eradication is accompanied by restoration of a ‘healthy’ microbiota resembling the composition of the donor microbiota (Khoruts et al., 2010).”
BackgroundAntibiotic treatment for Clostridium difficile -associated diarrhea in adults
Nelson, R. L., Kelsey, P., Leeman, H., Meardon, N., Patel, H., Paul, K., Rees, R., Taylor, B., Wood, E., & Malakun, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004610.pub4 · Cited by 43
Clostridium difficile colitis: A clinical review
Ong, G. K. B., Reidy, T. J., Huk, M. D., & Lane, F. R. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2016.10.035 · Cited by 47
Ierardi, E., Losurdo, G., Sorrentino, C., Giorgio, F., Rossi, G., Marinaro, A., Romagno, K. R., Leo, A. D., & Principi, M. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1086020 · Cited by 41
“has been observed 14 days after transplantation [25], thus hypothesizing a favorable effect against obesity.”
BackgroundPart 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.
Bull, M. J., & Plummer, N. T. (2015) · PubMed Central · Cited by 54
Dietary fiber during gestation improves lactational feed intake of sows by modulating gut microbiota
Li, S., Zheng, J., He, J., Liu, H., Huang, Y., Huang, L., Wang, K., Zhao, X., Feng, B., Che, L., et al. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00870-z · Cited by 45
Broecker, F., Kube, M., Klumpp, J., Schuppler, M., Biedermann, L., Hecht, J., Hombach, M., Keller, P. M., Rogler, G., & Moelling, K. (2013) · Digestion · doi:10.1159/000355955 · Cited by 41
Choi, H. K., Kim, K. H., Lee, S. H., & Lee, S. J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.7.859 · Cited by 40
“681 Clinical outcome Time to recovery, days Severe CDI Shock Acute kidney injury Duration of hospitalization, days (outpatient excluded) 4 (1-40) 9 (10.”
BackgroundRestoring the gut microbiome for the treatment of inflammatory bowel diseases
Allegretti, J. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3468 · Cited by 43
Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
Schwenger, K. J. P., Bolzon, C. M., Li, C., & Allard, J. P. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1844-5 · Cited by 43
Cui, J., Lin, Z., Tian, H., Yang, B. K., Zhao, D., Ye, C., Li, N., Qin, H., & Chen, Q. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.710452 · Cited by 41
Garey, K. W., McPherson, J. K., Dinh, A. Q., Hu, C., Jo, J., Wang, W., Lancaster, C. K., Gonzales-Luna, A. J., Loveall, C., Begum, K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac096 · Cited by 40
“[4-6] CDI recurrence is due to the continued perturbation of the gut microbiome, most commonly characterized by decreased proportions of Firmicutes, Bacteroidetes, and Actinobacteria phyla with subsequent overgrowth of Proteobacteria.[7] These taxa changes reduce colonization resistance to C.”
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection
Adamu, B. O., & Lawley, T. D. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.009 · Cited by 48
Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome
Zhang, Y., Lun, C.-Y., & Tsui, S. K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125957 · Cited by 42
“Additionally, of all the worldwide concerned infectious diseases mentioned above, investigations in the alteration of microbiome have also been conducted upon the infection with HPV, rotavirus, Salmonella, Clostridium difficile, and enteropathogenic Citrobacter rodentium [101–108], or to clarify its relationships with…”
BackgroundRichness and Composition of Niche-Assembled Viral Pathogen Communities
Seabloom, E. W., Borer, E. T., Lacroix, C., Mitchell, C. E., & Power, A. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055675 · Cited by 39
“in effects from pathogenic to mutualistic [22,23,24,25,26,27], and”
BackgroundJeong, J.-Y., Park, H., Lee, K.-H., Weon, H., & Ka, J.-O. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-0530-6 · Cited by 38
Fecal Bacteriotherapy, Fecal Transplant, and the Microbiome
Floch, M. H. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e1d6e2 · Cited by 41
Fecal microbiota transplantation: History, procedure and regulatory considerations
Thanush, D., & Venkatesh, M. P. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104204 · Cited by 44
Mirror, mirror on the wall: which microbiomes will help heal them all?
Nayak, R. R., & Turnbaugh, P. J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0622-6 · Cited by 36
“The microbiome can also be readily modified by diet [54], antibiotics [55], or fecal transplantation [56].”
BackgroundTreatment of Recurrent and Severe Clostridium Difficile Infection
Keller, J. J., & Kuijper, E. J. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-070813-114317 · Cited by 35
Management of Clostridium difficile Infection.
Al-Jashaami, L., & DuPont, H. L. (2016) · PubMed Central · Cited by 47
van Beurden, Y. H., Nieuwdorp, M., van de Berg, P. J. E. J., Mulder, C. J. J., & Goorhuis, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17690480 · Cited by 36
“The observation that the gut microbiota of the recipient resembles that of the donor indicates that the donors’ microorganisms are capable of restoring the structure and function of the gut microbiota of the patient [Khoruts et al. 2010].”
Background
Metadata
- Authors
- Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J.
- Affiliations
- University of Minnesota (US)
- Swedish University of Agricultural Sciences (SE)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Khoruts, Alexander
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-05
- Volume
- 44
- Issue
- 5
- Pages
- 354-360
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2095040140
- Cited by
- 649
- References
- 37
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 22 · 2023: 14 · 2022: 13 · 2021: 26 · 2020: 29 · 2019: 41 · 2018: 49 · 2017: 49 · 2016: 53 · 2015: 49 · 2014: 69 · 2013: 88 · 2012: 47
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile-associated diarrhea, fecal microbiota transplantation, gut microbiota composition, colonic microbiota, Firmicutes, Bacteroidetes, Bacteroides, butyrate-producing bacteria, antibiotic-associated diarrhea
- MeSH terms
- Enterocolitis, Pseudomembranous, Feces, Female, Follow-Up Studies, Humans, Middle Aged, Polymorphism, Restriction Fragment Length, RNA, Ribosomal, 16S, Clostridioides difficile, Sequence Analysis, RNA, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.